PCD Franchise

PCD Pharma Franchise Opportunities in Ladakh with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Ladakh with Daksh Diabetes and Cardiac Care Recent health data reveals that Ladakh is witnessing a rapid rise in lifestyle diseases, particularly diabetes and hypertension, driven by unique geographical, dietary, and lifestyle factors. The Union Territory’s population of approximately 2.9 lakh, spread across the challenging terrain of the Himalayas, faces distinct healthcare challenges that are compounded by extreme weather conditions, limited healthcare infrastructure, and traditional dietary patterns. According to the National Family Health Survey (NFHS-5), the prevalence of diabetes in the region has been showing an increasing trend. While specific prevalence data for Ladakh is limited, the overall national trends indicate a worrying picture, with the region mirroring the national pattern of rising non-communicable diseases. The primary drivers include the traditional Ladakh diet rich in high glycemic index foods like barley and wheat-based preparations, high saturated fat from ghee and cooking oils, and high salt intake from preserved foods combined with sedentary occupations due to urbanization, stressful living, and declining physical activity, all contributing to poor blood sugar regulation and awareness gaps in self-care practices. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Ladakh families through regular screening, medication adherence, lifestyle modifications, and early detection – ensuring thousands become success stories of integrated care and better health outcomes. How Daksh is making a Difference in Ladakh 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Ladakh patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Ladakh Daksh works with hospitals, clinics, and pharmacies across Ladakh to ensure that quality medications reach every corner of the Union Territory. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the growing disease burden and low competition, there is immense potential to build a meaningful healthcare business while serving your community. Popular locations for PCD franchise opportunities in Ladakh include Leh, Kargil, and Nubra Valley. The low investment requirements and monopoly rights in selected territories make these regions attractive for new franchise businesses. Conclusion The diabetes and heart disease burden in Ladakh is not just a statistic it is a reality affecting thousands of families. With the rising prevalence of diabetes and hypertension, limited healthcare access, and unique lifestyle challenges, there is an urgent need for quality medications and healthcare services. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Ladakh with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Jammu and Kashmir with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Jammu and Kashmir with Daksh Diabetes and Cardiac Care Recent data from the ICMR-INDIAB study reveals that Jammu and Kashmir is facing an alarming health crisis, with diabetes and hypertension reaching epidemic proportions across the Union Territory. According to the landmark ICMR-INDIAB national study, the overall prevalence of diabetes in Jammu stands at a staggering 18.9%, with an alarming 26.5% in urban areas and 14.5% in rural areas. This means nearly one in five adults in Jammu is living with diabetes, a figure almost double the national average. The burden of prediabetes is equally concerning, affecting 10.8% of the population—with urban areas showing 13.4% and rural areas 9.3% . Alarmingly, 40% of individuals had undiagnosed diabetes, highlighting a massive gap in screening and early detection. This means many are unaware of their condition until complications develop. Studies across Kashmir show that around 19% of adults in the Union Territory live with diabetes, placing the region among the highest in North India. The burden of hypertension adds another layer of concern. According to NFHS-5, only 36% of women and 31% of men in Jammu and Kashmir have normal blood pressure, with 57% of the population falling in the pre-hypertensive category. This means over half the population is at immediate risk of developing full-blown hypertension. The overall prevalence of hypertension in Jammu is 27.1%. A study among the tribal Gujjar and Bakarwal populations found an even higher hypertension prevalence of 41.4%. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers J&K families through regular screening, medication adherence, lifestyle modifications, and early detection ensuring thousands become success stories of integrated care and better health outcomes. How Daksh is making a Difference in Jammu and Kashmir 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for J&K patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Jammu and Kashmir Daksh works with hospitals, clinics, and pharmacies across Jammu and Kashmir to ensure that quality medications reach every corner of the Union Territory. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the region’s high disease burden and growing healthcare sector, there is immense potential to build a meaningful healthcare business while serving your community. Popular locations for PCD franchise opportunities include Srinagar, Jammu, Anantnag, Baramulla, Udhampur, Kathua, and Rajouri. Conclusion The diabetes and heart disease epidemic in Jammu and Kashmir is not just a statistic it is a reality affecting hundreds of thousands of families. With the Union Territory recording an 18.9% diabetes prevalence, a 27.1% hypertension prevalence, and 40% of diabetics undiagnosed, the burden is immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Jammu and Kashmir with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Delhi with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Delhi with Daksh Diabetes and Cardiac Care Recent data paints a stark picture of Delhi’s escalating health crisis, establishing the national capital as a major hotspot for diabetes and hypertension in India. The Center for cArdio-metabolic Risk Reduction in South Asia (CARRS) Study found that a staggering 72.7% of Delhi’s adult population has either diabetes or prediabetes, with 25.2% already diagnosed with diabetes and 47.6% in the prediabetes stage. This means nearly three in four adults in Delhi are either diabetic or on the verge of becoming diabetic. The burden is not limited to diabetes. A 2025 study on hypertension in Delhi found that while the overall prevalence of hypertension was 12.2%, the prevalence of prehypertension was a concerning 54.3%. This indicates that more than half of adults are at immediate risk of developing full-blown hypertension. In rural Delhi, the situation is even more severe, with hypertension prevalence reaching 35.7%. Alarmingly, only 14.6% of those with hypertension had their blood pressure under control, highlighting a massive gap in treatment and management. Obesity, a key driver of both diabetes and hypertension, has reached epidemic proportions. The National Family Health Survey (NFHS-6) shows that 41.4% of women and over 38% of men in Delhi are overweight or obese. The Economic Survey further revealed that 41.3% of women in Delhi are obese compared to 38% of men. This obesity crisis, combined with high-income levels, sedentary lifestyles, and poor dietary habits, is fueling the rapid rise of non-communicable diseases. NCDs already account for a significant portion of deaths in the capital, with circulatory diseases (heart and blood vessel conditions) being the leading cause of death. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Delhi families through regular screening, medication adherence, lifestyle modifications, and early detection – ensuring thousands become success stories of integrated care and better health outcomes. How Daksh is making a Difference in Delhi 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Delhi patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Delhi Daksh works with hospitals, clinics, and pharmacies across Delhi and the National Capital Region (NCR) to ensure that quality medications reach every corner of the capital. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the city’s high disease burden, a rapidly growing healthcare sector, and the advantage of monopoly rights to eliminate internal competition, there is immense potential to build a meaningful healthcare business while serving your community. Conclusion The diabetes and heart disease epidemic in Delhi is not just a statistic it is a reality affecting millions of families. With the national capital recording a 72.7% prevalence of diabetes or prediabetes, a hypertension prevalence of 35.7% in rural areas, and obesity rates exceeding 41%, the burden is immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Delhi with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Chandigarh with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Chandigarh with Daksh Diabetes and Cardiac Care Recent data from the National Family Health Survey (NFHS-6) 2023-24 paints a stark picture of Chandigarh’s escalating metabolic crisis. The survey reveals that 48.5% of adult men are now overweight or obese, marking a sharp rise from 34.4% in NFHS-5 and nearly double the national average of 27.3%. Among women, 41.9% are overweight or obese, significantly higher than the national average of 30.7%. This obesity crisis is directly fueling Chandigarh’s reputation as a diabetes hotspot. The survey found that 17.1% of men and 17.8% of women have high blood sugar levels or are on diabetes medication. Specifically, 10% of women and 9.8% of men recorded very high blood sugar levels above 160 mg/dl. An ICMR study has confirmed that nearly one in four Chandigarh residents suffers from diabetes or prediabetes. The burden of hypertension adds another layer of concern. NFHS-6 shows that 24.4% of men and 22.4% of women have elevated blood pressure. Alarmingly, 40% of registered NCD patients reported a positive family history, and experts note that obesity acts as the ultimate catalyst your DNA dictates whether it triggers diabetes or hypertension first. Noncommunicable diseases (NCDs) like cancer, heart attacks, and strokes already account for nearly 75% of all deaths in Chandigarh. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Chandigarh families through regular screening, medication adherence, lifestyle modifications, and early detection ensuring thousands become success stories of integrated care and better health outcomes. How Daksh is making a Difference in Chandigarh 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Chandigarh patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Chandigarh Daksh works with hospitals, clinics, and pharmacies across Chandigarh and its Tricity area (Mohali, Panchkula) to ensure that quality medications reach every corner. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. The diabetes and heart disease epidemic in Chandigarh is not just a statistic it is a reality affecting thousands of families. With the city recording a 48.5% male obesity rate, a 17.1% diabetes prevalence among men, and hypertension affecting nearly a quarter of adults, the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. With the city’s low initial investment requirements and monopoly rights in selected territories, there is immense potential to build a meaningful healthcare business while serving your community. Conclusion Daksh Diabetic & Cardiac Care is committed to being part of this solution providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details   Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India   Phone 📞 +91 93565 60523 📞 +91 78886 02869   Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Chandigarh with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Andaman and Nicobar with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Andaman and Nicobar with Daksh Diabetes and Cardiac Care Recent health data reveals that lifestyle diseases, particularly diabetes and hypertension, are emerging as significant health challenges in the Andaman and Nicobar Islands. As a Union Territory with a unique geographic and demographic profile, the islands face a distinct set of healthcare challenges. The population of approximately 4.5 lakh is spread across numerous islands, with a mix of indigenous communities and settlers from mainland India. According to the National Family Health Survey, the prevalence of diabetes and hypertension in the Andaman and Nicobar Islands has been showing an increasing trend, mirroring the national pattern of rising non-communicable diseases. While specific prevalence data for the Union Territory is limited, the overall national trends indicate a worrying picture. A community-based study in the Andaman and Nicobar Islands found that the prevalence of diabetes was higher than the national average. The primary drivers include dietary shifts away from traditional fish and rice-based diets towards more processed foods, combined with sedentary occupations, stressful living, and declining physical activity, all contributing to poor blood sugar regulation and awareness gaps in self-care practices. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers families in the Andaman and Nicobar Islands through regular screening, medication adherence, lifestyle modifications, and early detection – ensuring thousands become success stories of integrated care and better health outcomes. How Daksh is making a Difference in Andaman and Nicobar Islands 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Andaman and Nicobar Islands patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across the Islands Daksh works with hospitals, clinics, and pharmacies across the Andaman and Nicobar Islands to ensure that quality medications reach every corner of the Union Territory. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the growing disease burden and limited competition, there is immense potential to build a meaningful healthcare business while serving your community. Conclusion The diabetes and heart disease burden in the Andaman and Nicobar Islands is not just a statistic it is a reality affecting thousands of families. With the rising prevalence of diabetes and hypertension, limited healthcare access, and low competition, there is an urgent need for quality medications and healthcare services. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Andaman and Nicobar with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Uttar Pradesh with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Uttar Pradesh with Daksh Diabetes and Cardiac Care Recent data reveals that lifestyle diseases, particularly diabetes and heart conditions, are reaching epidemic proportions across Uttar Pradesh. With over 240 million people, the state presents a massive and growing demand for medicines, nutraceuticals, and healthcare products, with cities like Lucknow, Kanpur, Varanasi, and Agra emerging as key pharmaceutical hubs. The primary drivers include the traditional Uttar Pradesh diet—rich in high glycemic index foods, deep-fried snacks, and sugar-rich sweets—combined with sedentary occupations, stressful urban living, declining physical activity, and late-night eating habits, all contributing to poor blood sugar regulation. The expanding private hospital and clinic network has created a strong demand for generic medicines, antibiotics, and chronic care products, with the pharmaceutical business in Uttar Pradesh expanding rapidly due to fast-growing cardiac, diabetic, orthopaedic, and gastro medicine segments.  The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar – it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Uttar Pradesh families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Uttar Pradesh 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Uttar Pradesh patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Uttar Pradesh Daksh works with hospitals, clinics, and pharmacies across Uttar Pradesh to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and massive population, there is immense potential to build a meaningful healthcare business while serving your community. Popular Locations for PCD Pharma Franchise in Uttar Pradesh PCD pharma franchise PCD pharma franchise in Lucknow Cardiac diabetic PCD company in Lucknow PCD pharma franchise in Kanpur Cardiac diabetic products in Kanpur PCD pharma franchise in Varanasi Diabetic cardiac PCD franchise in Varanasi PCD pharma franchise in Agra Cardiac diabetic PCD company in Agra PCD pharma franchise in Prayagraj Cardiac diabetic products in Prayagraj PCD pharma franchise in Meerut Diabetic cardiac PCD franchise in Meerut PCD pharma franchise in Ghaziabad Cardiac diabetic PCD company in Ghaziabad PCD pharma franchise in Noida Cardiac diabetic products in Noida PCD pharma franchise in Gorakhpur Diabetic cardiac PCD franchise in Gorakhpur PCD pharma franchise in Bareilly Cardiac diabetic PCD company in Bareilly Conclusion The diabetes and heart disease epidemic in Uttar Pradesh is not just a statistic – it is a reality affecting millions of families. Many individuals are silently struggling with these conditions, often unaware of their impact on long-term health. But there is hope. With the right medications, proper awareness, and accessible healthcare, diabetic and cardiac patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution – providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Uttar Pradesh with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Telangana with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Telangana with Daksh Diabetes and Cardiac Care Recent health data reveals that Telangana is witnessing a rapid and alarming rise in lifestyle diseases, particularly diabetes and hypertension, positioning the state as a major hub for non-communicable diseases. According to the National Family Health Survey (NFHS-6) 2023-24, the prevalence of diabetes in Telangana has increased sharply, with 24.5% of men and 19.6% of women aged 15 and above now having high blood sugar levels or taking medication to control diabetes. This marks a significant spike from the previous NFHS-5 survey (2019-21), where diabetes prevalence stood at 14.7% for women and 19.6% for men. The burden of hypertension is equally concerning. NFHS-6 found that 29.5% of men and 26.4% of women in Telangana suffer from high blood pressure or take blood pressure medication. Adding to this, the ICMR study on prehypertension found that 28.2% of the population in Telangana is in the prehypertension stage, indicating a massive at-risk group that could develop full-blown hypertension without intervention. The scale of the crisis is further underscored by a massive population-based health screening drive in Telangana, which identified 26.9 lakh people with hypertension and another 14 lakh with diabetes, revealing that a significant portion of the population was unaware of their condition until tested. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Telengana families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Telangana 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Telangana patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Telangana Daksh works with hospitals, clinics, and pharmacies across Telangana to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden, growing healthcare demand, and expanding pharma ecosystem, there is immense potential to build a meaningful healthcare business while serving your community. The PCD model offers monopoly rights, low investment with high profit margins, and comprehensive marketing support, making it an attractive opportunity for aspiring entrepreneurs. Popular Locations for PCD Pharma Franchise in Telangana PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Hyderabad Cardiac diabetic PCD company in Hyderabad PCD pharma franchise in Warangal Cardiac diabetic products in Warangal PCD pharma franchise in Karimnagar Diabetic cardiac PCD franchise in Karimnagar PCD pharma franchise in Nizamabad Cardiac diabetic PCD company in Nizamabad PCD pharma franchise in Khammam Cardiac diabetic products in Khammam PCD pharma franchise in Ramagundam Diabetic cardiac PCD franchise in Ramagundam PCD pharma franchise in Mahbubnagar Cardiac diabetic PCD company in Mahbubnagar PCD pharma franchise in Adilabad Cardiac diabetic products in Adilabad PCD pharma franchise in Suryapet Diabetic cardiac PCD franchise in Suryapet PCD pharma franchise in Siddipet Cardiac diabetic PCD company in Siddipet Conclusion The diabetes and heart disease epidemic in Telangana is not just a statistic it is a reality affecting millions of families. With the state recording a diabetes prevalence of 24.5% among men and 19.6% among women, a hypertension prevalence of 29.5% among men and 26.4% among women, and the hidden epidemic of 26.9 lakh with hypertension and 14 lakh with diabetes uncovered through screening drives, the burden is already immense and growing . But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Telangana with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Tamil Nadu with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Tamil Nadu with Daksh Diabetes and Cardiac Care Recent health data reveals that Tamil Nadu has become a hotspot for India’s diabetes epidemic, with the prevalence of the disease more than doubling over the past decade. According to an ICMR–INDIAB study, the prevalence of diabetes in people over the age of 20 in Tamil Nadu was 11.1% between 2008 and 2010, which increased to 22.7% in 2022–2023, representing a 104% increase. Meanwhile, the prevalence of prediabetes rose from 12.2% to a staggering 24.8%, a 103% increase. This means there are about 12 million people who already have diabetes in the state, and another 10 million who will develop it in the next few years unless serious steps are taken. The epidemic is not merely an urban phenomenon. Rates of diabetes in rural Tamil Nadu rose from 8.3% to 18.3% during the same period, representing a 120% increase rural prevalence is rising even faster than in urban areas. A state-wide STEPS survey conducted by the ICMR-National Institute of Epidemiology found that the overall prevalence of hypertension in Tamil Nadu is 33.9% and that of diabetes is 17.6% among adults aged 18-69. The survey also found that 28.5% of the population is overweight and 11.4% is obese. Non-communicable diseases account for nearly 75% of all deaths in Tamil Nadu. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Tamil Nadu families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Tamil Nadu 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Tamil Nadu patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Tamil Nadu Daksh works with hospitals, clinics, and pharmacies across Tamil Nadu to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and growing pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community. Popular Locations for PCD Pharma Franchise in Tamil Nadu PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Chennai Cardiac diabetic PCD company in Chennai PCD pharma franchise in Coimbatore Cardiac diabetic products in Coimbatore PCD pharma franchise in Madurai Diabetic cardiac PCD franchise in Madurai PCD pharma franchise in Trichy Cardiac diabetic PCD company in Trichy PCD pharma franchise in Salem Cardiac diabetic products in Salem PCD pharma franchise in Tirunelveli Diabetic cardiac PCD franchise in Tirunelveli PCD pharma franchise in Vellore Cardiac diabetic PCD company in Vellore PCD pharma franchise in Erode Cardiac diabetic products in Erode PCD pharma franchise in Thanjavur Diabetic cardiac PCD franchise in Thanjavur PCD pharma franchise in Kanyakumari Cardiac diabetic PCD company in Kanyakumari Conclusion The diabetes and heart disease epidemic in Tamil Nadu is not just a statistic—it is a reality affecting millions of families. With the state recording a 22.7% diabetes prevalence (a 104% increase over a decade), a rural diabetes prevalence of 18.3% (a 120% increase), and hypertension affecting 33.9%, the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution—providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Tamil Nadu with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Sikkim with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Sikkim with Daksh Diabetes and Cardiac Care Recent health data reveals that Sikkim has the highest proportion of hypertension among all Indian states, with prevalence significantly exceeding national averages of 16.2% for men and 10.7% for women. Analysis from the National Family Health Survey shows that the highest prevalence of prehypertension is also recorded in Sikkim, indicating a large population already at risk of developing full-blown hypertension. The burden of diabetes is equally concerning, with the state emerging as a hotspot for non-communicable diseases. A quality improvement study conducted in West Sikkim found that among 4,323 outpatient attendees aged 30 years and above, 35% were screened for diabetes and 12% were newly diagnosed with the condition. Screening coverage varied widely across facilities, ranging from just 9% to 100%, while the yield of new diagnoses varied from 0% to 36%. These figures point to substantial gaps in detection and the need for improved screening across the state. The primary drivers include Sikkim’s unique dietary patterns rich in high glycemic index foods like rice and wheat-based preparations, high saturated fat from cooking oils and meat, and sugar-rich sweets combined with sedentary occupations, stressful urban living in Gangtok and other towns, declining physical activity, and lifestyle changes associated with urbanization. A comprehensive health report also highlights a shortage of medical specialists, particularly in oncology and neurology, forcing residents to seek treatment outside the state and incurring substantial financial strain. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Sikkim families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Sikkim 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Sikkim patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin)  the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Sikkim Daksh works with hospitals, clinics, and pharmacies across Sikkim to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and growing pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community. Sikkim offers low competition in rural and semi-urban areas, making it an attractive market for new franchise businesses. Major locations for pharma franchise opportunities include Gangtok, Namchi, Mangan, Geyzing, Singtam, Rangpo, and Jorethang. Popular Locations for PCD Pharma Franchise in Sikkim PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Gangtok Cardiac diabetic PCD company in Gangtok PCD pharma franchise in Namchi Cardiac diabetic products in Namchi PCD pharma franchise in Mangan Diabetic cardiac PCD franchise in Mangan PCD pharma franchise in Geyzing Cardiac diabetic PCD company in Geyzing PCD pharma franchise in Singtam Cardiac diabetic products in Singtam PCD pharma franchise in Rangpo Diabetic cardiac PCD franchise in Rangpo PCD pharma franchise in Jorethang Cardiac diabetic PCD company in Jorethang PCD pharma franchise in Pakyong Cardiac diabetic products in Pakyong PCD pharma franchise in Ravangla Diabetic cardiac PCD franchise in Ravangla PCD pharma franchise in Yuksom Cardiac diabetic PCD company in Yuksom Conclusion The diabetes and heart disease burden in Sikkim is not just a statistic it is a reality affecting thousands of families. With the state recording the highest proportion of hypertension among all Indian states, a diabetes screening yield of 12% among newly diagnosed patients, and significant gaps in healthcare access, the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Sikkim with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Rajasthan with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Rajasthan with Daksh Diabetes and Cardiac Care Recent data reveals that lifestyle diseases, particularly diabetes and heart conditions, are reaching epidemic proportions across Rajasthan. With a population of over 74.79 million, the state presents a massive and growing demand for medicines, nutraceuticals, and healthcare products. According to the Ministry of Health and Family Welfare, the incidence rate of diabetes in Rajasthan stands at approximately 6.2%, with the state reporting over 4.6 million type 2 diabetics. A community-based health screening in a rural village of Rajasthan found that the prevalence of generalized obesity was 20% and abdominal obesity was 39% among the screened population. The prevalence of diabetes was significantly higher in obese individuals—15% in those with generalized obesity and 12% in those with abdominal obesity—compared to their non-obese counterparts. This indicates a strong link between obesity and diabetes in the state. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar – it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Rajasthan families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Rajasthan 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Rajasthan patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Rajasthan Daksh works with hospitals, clinics, and pharmacies across Rajasthan to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and expanding healthcare infrastructure, there is immense potential to build a meaningful healthcare business while serving your community. The pharmaceutical market in Rajasthan is growing at more than 12% every year due to rising healthcare awareness, increasing lifestyle diseases, and better healthcare services in both cities and rural areas. Popular Locations for PCD Pharma Franchise in Rajasthan PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Jaipur Cardiac diabetic PCD company in Jaipur PCD pharma franchise in Jodhpur Cardiac diabetic products in Jodhpur PCD pharma franchise in Udaipur Diabetic cardiac PCD franchise in Udaipur PCD pharma franchise in Kota Cardiac diabetic PCD company in Kota PCD pharma franchise in Ajmer Cardiac diabetic products in Ajmer PCD pharma franchise in Bikaner Diabetic cardiac PCD franchise in Bikaner PCD pharma franchise in Alwar Cardiac diabetic PCD company in Alwar PCD pharma franchise in Sikar Cardiac diabetic products in Sikar PCD pharma franchise in Bharatpur Diabetic cardiac PCD franchise in Bharatpur PCD pharma franchise in Pali Cardiac diabetic PCD company in Pali Conclusion The diabetes and heart disease epidemic in Rajasthan is not just a statistic – it is a reality affecting millions of families. Many individuals are silently struggling with these conditions, often unaware of their impact on long-term health. But there is hope. With the right medications, proper awareness, and accessible healthcare, diabetic and cardiac patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution – providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Rajasthan with Daksh Diabetes and Cardiac Care Read More »